Dovitinib

SI-6037

Dovitinib, >98% (HPLC)

CAS No. : [405169-16-6]

MDL No. : MFCD10565680

Synonyms : CHIR-258; TKI258

IUPAC Name : 4-Amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
100MG	125.00		In Stock	Estimated to ship on 20 September 2026
250MG	225.00		In Stock	Estimated to ship on 20 September 2026
500MG	425.00		In Stock	Estimated to ship on 20 September 2026
1G	825.00		In Stock	Estimated to ship on 20 September 2026
5G	2895.00		In Stock	Estimated to ship on 20 September 2026

Applications : Dovitinib is an orally active, potent multi-targeted tyrosine kinase (RTK) inhibitor for the potential treatment of renal cell carcinoma (RCC).

References : Trudel S. et al.: Blood, 105(7), 2941-2948, 2005; Huynh H. et al.: J. Hepatol., 56(3), 595-601, 2012; Lee Y. et al.: Mol Cells 39(5), 389-94, 2016; Chon H. J. et al.: Amino Acids 48(7),1591-9, 2016.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.